Clinical Decision Support System Market Research Report Information by Component (Software, Services, and Hardware) By Product (Integrated CDSS and Standalone CDSS), By Model (Knowledge-Based CDSS and Non-Knowledge-Based CDSS), By Delivery Mode (On-Premise CDSS and Cloud-Based CDSS), By Mode of Advice (Active CDSS and Passive CDSS), By Setting (Inpatient Settings and Ambulatory Care Settings) By Type (Therapeutic Clinical Decision Support Systems and Diagnostic Clinical Decision Support Systems ), By Application (Advanced Clinical Decision Support Systems and Conventional Clinical Decision Support Systems), By Region (North America, Europe, Asia-Pacific, and Rest of the World) - Industry Forecast till 2032
The market for clinical decision support systems is expected to expand at a compound annual growth rate (CAGR) of 10.54%, from USD 3.67 billion in 2024 to USD 8.92 billion by 2032. The market is expanding because of favorable government laws, an aging population, and rising demand for data-driven technology.
The elderly population needs regular medical examinations and treatments since they are more likely to develop chronic illnesses. Therefore, as the number of elderly people rises, so does the strain on healthcare facilities. As a result, there is a greater need for technology like CDSS to deliver effective care. For example, the UN predicts that one in six persons worldwide will be over 65 by 2050, up from one in eleven in 2019. The Rural Health Information Hub estimates that by 2050, there will be about 90 million older persons in the US who are 65 and older. Furthermore, it is anticipated that one in five Americans would be 65 or older by 2030.
Perspectives on Market SegmentsThe market for clinical decision support systems is segmented by component, including hardware, software, and services.
Product-based market segmentation includes both standalone and integrated CDSS.
A paradigm comprising Knowledge-Based CDSS and Non-Knowledge-Based CDSS forms the basis of market segmentation.
On-premises and cloud-based clinical decision support systems are among the delivery modes that are used to segment the clinical decision support system market.
Active CDSS and Passive CDSS are two of the advising modes that form the basis of market segmentation.
Inpatient and ambulatory care settings are included in the market segmentation based on setting.
Therapeutic and diagnostic clinical decision support systems are among the types of clinical decision support systems that make up the market segmentation for clinical decision support systems.
Both traditional and advanced clinical decision support systems are included in the market segmentation depending on application.
Regional PerspectivesIn 2023, the market for clinical decision support systems in North America held the biggest share. This is because chronic illnesses including cancer, heart disease, diabetes, obesity, and arthritis are becoming more common in North America.
Because of the region's easy access to cutting-edge treatment facilities, the clinical decision support system market in Europe holds the second-largest market share.
The market for clinical decision support systems in the Asia-Pacific region is anticipated to expand significantly because of factors like the region's growing patient population with chronic illnesses like cancer, orthopedic conditions, and cardiovascular diseases, as well as the region's improving healthcare infrastructure.
Key PlayersSiemens (Germany), Veradigm LLC (Allscripts Healthcare Solutions Inc.) (US), Oracle Corporation (US), IBM (US), Carestream Health (US), Wolters Kluwer N.V. (Netherlands), Epic Systems Corporation (US), Chang Healthcare (US), Medical Information Technology, Inc. (US), and Computer Programs and Systems, Inc. (US) are important players in the clinical decision support system market.